Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Κύριος συγγραφέας: | Tamanna, Mst. Taskia |
---|---|
Άλλοι συγγραφείς: | Sharmin, Dr. Sabrina |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
Brac University
2023
|
Θέματα: | |
Διαθέσιμο Online: | http://hdl.handle.net/10361/18146 |
Παρόμοια τεκμήρια
-
Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
ανά: Hassan, Md. Muhtaz
Έκδοση: (2020) -
Role of protein’s and future treatment options for Alzheimer’s Disease
ανά: Islam, Md. Irfath
Έκδοση: (2023) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
ανά: Alim, Abdul
Έκδοση: (2023) -
Marine compounds in the treatment of Alzheimer’s disease
ανά: Parveen, Sanjana
Έκδοση: (2022) -
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
ανά: Tabassum, Nadira
Έκδοση: (2024)